In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...

A painkiller meant for relief now faces tighter scrutiny as abuse concerns spill into policy.

Neuropathic pain, often referred to as nerve pain, can arise from a range of conditions such as diabetic neuropathy, nerve ...

Understanding both sides of this medication is essential before starting or continuing to take it.

Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...

The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...

More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.

Nerve discomfort rarely appears as a single, obvious issue. For many adults, it begins quietly with occasional tingling, ...

By Tarun Sai Lomte Two-year data show that adding VNS to standard care can produce lasting symptom, function, and ...

There’s growing awareness of rare, but potentially serious side effects from mega doses of vitamin B6, a nutrient found in supplements and energy drinks.